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Macrophages possess numerous mechanisms to
combat microbial invasion, including sequestration
of essential nutrients, like zinc (Zn). The pleiotropic
cytokine granulocyte macrophage-colony stimu-
lating factor (GM-CSF) enhances antimicrobial
defenses against intracellular pathogens such as
Histoplasma capsulatum, but its mode of action
remains elusive. We have found that GM-CSF-acti-
vated infected macrophages sequestered labile Zn
by inducing binding to metallothioneins (MTs) in
a STAT3 and STAT5 transcription-factor-depen-
dent manner. GM-CSF upregulated expression of
Zn exporters, Slc30a4 and Slc30a7; the metal
was shuttled away from phagosomes and into the
Golgi apparatus. This distinctive Zn sequestration
strategy elevated phagosomal H+ channel function
and triggered reactive oxygen species generation
by NADPH oxidase. Consequently, H. capsulatum
was selectively deprived of Zn, thereby halting repli-
cation and fostering fungal clearance. GM-CSF
mediatedZn sequestration viaMTs in vitro and in vivo
in mice and in human macrophages. These findings
illuminate a GM-CSF-induced Zn-sequestration
network that drives phagocyte antimicrobial effector
function.
INTRODUCTION
Zinc (Zn) is an abundant transition metal in living organisms. It is
essential in immune homeostasis and function, and Zn defi-
ciency has been associated with thymic atrophy, impaired B,
T, and NK cell responses, and T helper-1 (Th1) cytokine produc-
tion (Fraker et al., 1986). Zn also functions in intracellular
signaling (Hirano et al., 2008). Such a wide association with
cellular functions requires strict regulation of Zn.Availability of Zn to biomolecules is tightly regulated by binding
proteins, metallothioneins (MTs), and Zn transporters. MTs are
cysteine-rich proteins that bind up to seven Zn ions with picomo-
lar affinity and carry the labile Zn fraction to cellular compart-
ments. MTs are induced during oxidative stress, scavenge
reactive oxygen species (ROS), and reduce heavy metal intoxi-
cation (Coyle et al., 2002).
Macrophages provide a crucial role in immune defense; they
phagocytose and kill intracellular pathogens by oxidative burst,
nitric oxide production (Fang, 1997), and T cell activation
(Mosser, 2003). ‘‘Nutritional immunity’’ signifies deprivation of
essential nutrients to pathogens, thereby exerting an antimicro-
bial effect (Appelberg, 2006). In this regard, interferon-g (IFN-g)
deprives Fe in macrophages by regulating transferrin receptors
and the transporter Slc11a1 (Nairz et al., 2008; Zwilling et al.,
1999). In contrast, macrophages may intoxicateMycobacterium
tuberculosis with Zn in phagosomes (Botella et al., 2011). Zn
competitively inhibits Mn binding to an essential virulence deter-
minant in Streptococcus pneumoniae (McDevitt et al., 2011),
rendering it inactive. Thus, bothmetal starvation and intoxication
are part of the arsenal employed by macrophages in host
defenses.
Apart from directly exploiting metals for combating patho-
gens, immune cells also need them for activation of defense
mechanisms. In this regard, modulation of Zn activates microglia
(Kauppinen et al., 2008) and dendritic cells (Kitamura et al., 2006)
by altering surface markers and cytokine expression. Thus, Zn
regulation is crucial in determining the outcome of an infectious
process.
The fungal pathogen H. capsulatum is distributed worldwide
and causes pulmonary and disseminated histoplasmosis, partic-
ularly in immunocompromised patients. For clearance of infec-
tion, coordinated action of innate and adaptive immunity is
essential. The fungus gains entry into the host primarily via pul-
monary route, is phagocytosed, and replicates within resting
macrophages (Howard, 1964). Activation of macrophages with
IFN-g or GM-CSF promotes fungal growth inhibition. Whereas
IFN-g acts only on murine macrophages in vitro, GM-CSF in-
hibits growth of yeasts in both murine and human macrophages
(Newman and Gootee, 1992). A lack of GM-CSF is lethal duringImmunity 39, 697–710, October 17, 2013 ª2013 Elsevier Inc. 697
Figure 1. GM-CSF Distinctly Modulates Zn-Distribution in Infected Macrophages
(A and B) Total concentration of Zn by ICP-MS in lysates from peritoneal and bone-marrow macrophages, and total Zn analysis by ICP-MS in H. capsulatum (Hc)
recovered from macrophages and compared with yeasts grown in Ham’s F12 media. Data are mean ± SD, four independent experiments. The cell lysate
(legend continued on next page)
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GM-CSF Drives Zinc Sequestrationinfection and treatment with recombinant GM-CSF accelerates
fungal clearance (Deepe et al., 1999).
We have reported that Zn is essential for survival of
H. capsulatum within macrophages and chelation causes
drastic retardation of fungal growth (Winters et al., 2010).
Here, we elucidate a mechanism by which GM-CSF activates
macrophages to preferentially sequester Zn while enhancing
ROS production and denying the intracellular pathogen access
to this element. By using a murine pulmonary model of
H. capsulatum infection in vivo, we reveal the significance of
GM-CSF in Zn sequestration by MTs in infected macrophages.
Finally, we have shown that this effect of GM-CSF is conserved
in human macrophages.
RESULTS
GM-CSF Modulates Total Zn and Zn Proteome
Distribution
An unbiased, inductively coupled plasma-mass spectrometry
(ICP-MS) total elemental analysis was performed to evaluate
changes in the concentration of Zn, Fe, Cu, and Mn in macro-
phage lysates and H. capsulatum itself. The total Zn concentra-
tion increased in GM-CSF-activated peritoneal macrophages
compared to the resting control and increased further in
activated peritoneal and bone-marrow macrophages during
infection with five yeasts per macrophage. In contrast, Zn
concentration was significantly reduced (p < 0.001) in
H. capsulatum recovered from activated macrophages in com-
parison to yeasts from resting peritoneal macrophages and me-
dia-cultured H. capsulatum, suggesting that GM-CSF activation
induced deprivation of yeast-associated Zn. GM-CSF also
altered Fe within macrophages, but not in intracellular yeasts.
Meanwhile, activation did not alter the concentration of Cu and
Mn in macrophages and yeasts (Figures 1A and 1B). Thus,
GM-CSF specifically altered Zn flux in H. capsulatum-infected
peritoneal and bone-marrow macrophages.
To examine the Zn-proteome distribution in macrophages,
we used size-exclusion chromatography based on molecular
size via hydrodynamic radii coupled to ICP-MS (SEC-ICP-
MS). The Zn signal increased upon exposure to GM-CSF
compared to resting peritoneal macrophages and a greater in-
crease was seen upon activation and infection (Figure 1C). A
large increment in the Zn signal was observed in infected, acti-
vated bone-marrow macrophages compared to uninfected
control (Figure 1D). The relative Zn distribution between frac-
tions was altered; the principal change occurred at 20 min
(z20-7 kDa), representing a major portion of total Zn. This
correlated with a reduction in the labile, exchangeable Zn
pool appearing after 22 min in infected activated peritoneal
and bone-marrow macrophages (Figures 1E and 1F). Zn distri-concentrations are based on 2.5 3 106 cells in 200 ml; H. capsulatum concentra
follows: RP, resting peritoneal; Act, GM-CSF activated.
(C and D) Typical SEC-ICP-MS chromatograms of activated peritoneal and bone
(E and F) Left panel shows graphical representation of color-coded peaks depic
activated peritoneal and bone-marrow macrophages. Middle panel shows Zn dist
area; red and green boxes with **, ## symbol indicate significant differences in
mean ± SD, four independent experiments.
(G andH) Typical SEC-ICP-MS chromatograms of TNF-a treatedmacrophages, th
easy comparison under the same scale. Related to Figure S1 and Table S1.bution was altered dynamically as early as 2 hr and held a
similar trend for the 24 hr time period in infected activated peri-
toneal macrophages (see Figures S1A and S1B available
online).
To determine the specificity of GM-CSF in Zn modulation, we
treated macrophages with the proinflammatory cytokine, tumor
necrosis factor-a (TNF-a). TNF-a did not alter the Zn signal in
macrophages (Figures 1G and 1H).
GM-CSF Alters Zn Transporter Expression in
H. capsulatum-Infected Macrophages
We hypothesized that GM-CSF alters macrophage Zn distribu-
tion by regulating transporters. In an unbiased analysis of
expression of Zn importers, ZIPs (Slc39a1-14) and exporters,
ZNTs (Slc30a1-10), Slc39a2 was upregulated in activated in-
fected peritoneal and bone-marrow-derived macrophages by
60-fold and 40-fold, respectively, compared to the control (Fig-
ures 2A and 2C). A significant 2- to 4-fold increase in Slc30a4
and Slc30a7 (p < 0.001 for peritoneal and p < 0.05 for bone-
marrow macrophages) was also observed upon activation and
infection (Figures 2B and 2D). The expression of another
importer, Slc39a8, was unchanged (Figure S2A). TNF-a treat-
ment of did not alter Slc39a2, Slc30a4, and Slc30a7 expression
(Figure 2E). These data suggest that GM-CSF-activated infected
macrophages might increase Zn import andmobilize it into intra-
cellular organelles via exporters.
Proteomics Analysis of SEC Fractions
GM-CSF altered the Zn-binding proteome in macrophages. For
proteomics analysis, five fractions identified by SEC-ICP-MS
were collected with the plasma turned-off and analyzed with a
bottoms-up proteomics scheme. The list of identification param-
eters and proteins in all fractions and Zn-binding proteins high-
lighted in the fractions at 10 and 20 min are in Table S1.
The CCCH zinc-finger protein, ZC3H12A, calreticulin, and MT2
were selected as being potentially associated with immune
response and Zn binding. MT2 was detected in the peak that
scavenged a majority of Zn at 20 min. MT1, MT3, and ZIP2
were not identified in database search. ZIP2 is located on the
cell membrane. The association of transmembrane proteins
with hydrophobic lipids and their insolubility poses a challenge
in proteomic analysis (Santoni et al., 2000). Peptide matching
is compromised by complex covalent hetero-oligomerization of
MT isoforms, likely explaining the absence of MT1 and MT3 as
hits in database search. We observed oligomerization at
20min based on a shift in retention time toward the highmolec-
ular weight region, with the peak showing maximal absorbance
at 260 nm, typical of -S-S- bonds formed by MTs during oligo-
merization, and not 280 nm, representative of Trp and Tyr con-
taining proteins (Figure S1C).tion was calculated based on mass of yeasts recovered. Abbreviations are as
-marrow macrophages, compared to resting conditions.
ting Zn distribution in various MW fractions in the chromatograms of infected
ribution calculated as area under the curve of individual peaks against the total
the corresponding color-coded fractions between different groups. Data are
ree independent experiments. The y axis in all chromatograms is offset to allow
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Figure 2. GM-CSF Alters Zn Transporter and MT Expression
qRT-PCR of Slc39a and Slc30a in (A and B) peritoneal, (C and D) bone marrow, and (E) TNF-a treated macrophages. Data are mean ± SEM, three independent
experiments.
(F andG)Mt1,Mt2, andMt3 expression inmacrophages. Abbreviations are as follows: RP, resting peritoneal; Act, GM-CSF activated; Hc,H. capsulatum; ND, not
detected. Data are mean ± SEM, eight independent experiments. Related to Figure S2.
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Macrophages
GM-CSF enhanced Zn binding to the20min fraction in infected
macrophages (Figures 1C and 1D). Proteomic analysis and UV-700 Immunity 39, 697–710, October 17, 2013 ª2013 Elsevier Inc.Vis spectral characteristics suggested a major contribution of
MTs to this Zn signal (Figures S1C–S1E). Therefore, we exam-
ined the effect of GM-CSF on Mt expression. GM-CSF, but not
TNF-a, increasedMt1,Mt2, andMt3 expression inmacrophages
Figure 3. GM-CSF, but Not TNF-a Triggers
Zn Mobilization
(A–H) Confocal microscopic analysis of Zn (green),
nucleus (blue), and H. capsulatum (Hc) (red) in
(A–E) peritoneal and (F–H) bone-marrow macro-
phages, merge, overlay of Zn, nucleus, and
H. capsulatum.
(I) Staining for Zn (green), nucleus (blue), and Golgi
(red). Merge, overlay of Zn, nucleus, and Golgi.
Yellow shows colocalization of Golgi and Zn dyes;
white arrows point at the Golgi. Scale bars repre-
sent 20 mm, three independent experiments. Ab-
breviations are as follows: RP, resting peritoneal;
Act, activated; P macrophage, peritoneal macro-
phage. Related to Figure S3.
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GM-CSF Drives Zinc Sequestrationduring infection (Figures 2F and 2G). Mt3 is predominantly ex-
pressed in the brain (Falnoga et al., 2012). To ensure that our
findings were valid, Mt3 was examined in hepatocytes and thy-Immunity 39, 697–710,mocytes and was not upregulated (Fig-
ure S2B). Expression of the Zn finger ribo-
nuclease, Zc3h12a, was enhanced in
infected macrophages but was not spe-
cific to GM-CSF (Figures S2D and S2E).
GM-CSF did not alter the expression of
calreticulin or the metal response
element-binding transcription factor-1
(Mtf1), which regulates Mt expression
(Figure S2C and S2F). Thus, GM-CSF
specifically induced Mt expression.
GM-CSF Mobilizes Labile Zn away
from H. capsulatum
Confocal microscopy was used to visu-
alize labile Zn with the fluorescent probe,
Zinpyr-1 (Cao et al., 2001). Uninfected
resting peritoneal macrophages showed
labile Zn distribution in the cytoplasm
and epinuclear space (Figure 3A); how-
ever, Zn staining was diffuse in infected
resting peritoneal macrophages (Fig-
ure 3C). GM-CSF activation caused focal
Zn accumulation (Figures 3B and 3F) and
mobilized Zn away from H. capsulatum
(Figures 3D and 3G) into the Golgi appa-
ratus (Figure 3I). The reduced Zn fluores-
cence of yeasts observed in GM-CSF
activated macrophages was not due to
an impermeability of the dye (Figure S3A).
Previous reports suggest that Zinpyr-1
may localize in the Golgi (Walkup et al.,
2000). To ensure that labile Zn localization
was a result of cytokine stimulation, we
evaluated it in TNF-a treated macro-
phages. Zn distribution was nonfocal, no
or very little Zn staining was observed in
the Golgi, and labile Zn was observed in
yeast (Figures 3E and 3H). This is consis-
tent with lack of changes in Zn regulationin TNF-a treated macrophages (Figures 1G, 1H, 2E, and 2G).
Peritoneal macrophages treated with Zn and the ionophore pyr-
ithione yielded bright fluorescence, and very dim staining wasOctober 17, 2013 ª2013 Elsevier Inc. 701
Figure 4. GM-CSF Engages the STAT5 and STAT3 Transcriptional Program to Regulate MT-Zn Sequestration
(A) qRT-PCR ofMt genes in activated (Act) macrophages treated with scramble orMt siRNA, percentage decrease in expression compared to scramble siRNA
control. Data are mean ± SEM, two independent experiments.
(legend continued on next page)
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GM-CSF Drives Zinc Sequestrationobserved in cells treated with the Zn chelator N,N,N’,N’-tetrakis-
(2-pyridylmethyl)-ethylenediamine (TPEN) (Figures S3B and
S3C). Labile Zn was examined in alveolar macrophages, the
initial phagocyte that encounters H. capsulatum in vivo. While
staining occurred in the cytosol and Golgi in resting alveolar
macrophages, GM-CSF activation caused Zn localization in
the Golgi (Figures S3D-S3G). Collectively, these data suggest
that GM-CSF induced Zn redistribution in macrophages, which
may limit its accessibility to H. capsulatum.
Metallothioneins Sequester and Deprive H. capsulatum
of Zn
Because Zn regulation was similar in both types of macro-
phages, we utilized bone-marrow macrophages for further
studies. To determine whether Zn sequestration inmacrophages
and deprivation in H. capsulatum was caused by MTs, we took
two approaches. First, we silenced the expression of all four
Mt genes (Figure 4A). Mt-silenced macrophages manifested
reduced Zn binding to the chromatographic fraction at 20 min
accompanied by an increase in the labile Zn fraction at
25 min. (Figure 4B, zoom in). H. capsulatum recovered
from Mt silenced macrophages had higher Zn content (p <
0.01) (Figure 4C). Next, we examined Zn sequestration in
Mt1/Mt2/ macrophages. These cells exhibited a lack
of Zn-binding to the fraction at 20 min, accompanied by an
increase in labile Zn in GM-CSF treated and infected macro-
phages (Figure 4D, zoom in). H. capsulatum recovered from
Mt1/Mt2/ macrophages had higher Zn concentration (p <
0.01) compared to wild-type (WT) cells (Figure 4E). Thus, Zn
deprivation within H. capsulatum resulted preponderantly from
sequestration by MTs.
We queried whether MT1 and MT2 participated in antimicro-
bial defense. We postulated that the lack of Zn sequestration
in the absence of MT1 and MT2 would diminish the ability of
GM-CSF to inhibit fungal growth. While H. capsulatum growth
was inhibited in WT activated macrophages,Mt1/Mt2/ acti-
vated cells showed decreased ability to limit growth of yeasts
(Figure 4F).
GM-CSF Engages the STAT5 and STAT3 Transcriptional
Program to Mediate Zn Regulation
We sought to determine the signalingmechanism that resulted in
Zn modulation. GM-CSF signals through STAT5 (Bhattacharya
et al., 2001) and STAT binding sites are present on the Mt pro-
moter (Lee et al., 1999). Inhibition of STAT5 and STAT3 reduced
MT-Zn binding (Figures 4G and 4H). To confirm our observations
with chemical inhibitors, we silenced Stat5 and Stat3, which
decreased Zn binding to MTs in the chromatograms of activated
infected macrophages (Figures 4I–4K).(B and D) SEC-ICP-MS chromatograms of Mt-silenced, activated infected (Hc) m
fraction, two independent experiments.
(C and E) Total metal analysis of Zn in H. capsulatum (Hc) from Mt-silenced and
periments.
(F) CFU of H. capsulatum 24 hr after infection from WT and Mt1/Mt2/-activa
independent experiments.
(G–J) SEC-ICP-MS chromatograms of chemically inhibited and Stat3 and Stat5
scramble siRNA-treated infected macrophages; y axis, offset Zn-signal, three in
(K) p-STAT3, p-STAT5, and b-actin from silenced macrophages 24 hr after activ
(L) Immunoblot of p-STAT3, STAT3, and b-actin from lysates 10 min after activaThese findings led us to postulate that GM-CSF might directly
activate STAT5 and STAT3 signaling. GM-CSF increased STAT3
phosphorylation 10 min after activation and infection, proving
that the cytokine directly activated STAT3 (Figure 4L). There
was >2.5- and >5-fold increase in Mt1 and Mt2 expression, as
early as 10 min after infection and remained high for 24 hr; Mt3
was modestly altered (Figure 5A). These data indicate that Zn
regulation by GM-CSF occurs via STAT5 and STAT3 signaling.
We investigated the importance of Slc39a2 in regulating GM-
CSF function. Activated infected macrophages manifested a
10-fold increase in Slc39a2 expression 10 min after infection
(Figure 5A). We questioned whether the regulation of Slc39a2
was a prerequisite in macrophage defense. Upregulation of Mt
genes was partially dependent on Slc39a2, but silencing
Slc39a2 did not alter Zn deprivation in H. capsulatum, ROS pro-
duction, or growth inhibition (Figures 5B and 5C; Figures S4A
and S4B). Slc39a2 silencing reduced Zn influx and MT-Zn signal
in macrophages but did not affect labile Zn sequestration (Fig-
ures 5C and 5D). To probe how MTs in these macrophages
established a defensive state against the pathogen, we
compared the amount of Zn bound per MT by determining the
[Zn] to [S] ratio (Zn2+ to MTs) between control and Slc39a2-
silenced macrophages. As expected, scramble small interfering
RNA (siRNA)-treated macrophages had increased MT and
sequestered labile Zn (Figure 5D). But the amount of Zn bound
to MTs in Slc39a2-silenced, infected macrophages was 2.4
fold greater than scramble siRNA-treated control, thereby
enabling efficient Zn sequestration (Figure 5E), even with lower
production of MTs. Silencing Slc39a14 did not affect GM-CSF
driven macrophage defense (Figures S4C–S4F).
Zn Sequestration Enhances Oxidative Burst
GM-CSF enhances ROS production (Weisbart et al., 1987).
Therefore, we asked whether Zn sequestration affected oxida-
tive burst during infection. GM-CSF increased ROS in macro-
phages. Zn chelation by TPEN in serum-freemedium augmented
ROS production by 40%, which was significantly higher (p <
0.05) compared to activated infected macrophages (Figure 6A).
This effect was reversed upon addition of ZnSO4 (p < 0.001). To
ensure that this was not due to chelation of other metals by
TPEN, we specifically depleted Zn from serum-free and serum-
containing media. Low-Zn serum-containing media did not
show a significant increase in ROS over activated infected mac-
rophages (Figure 6A), possibly as a result of the presence of re-
sidual Zn contributed by serum or serum-LPS that might have an
inhibitory effect on NADPH oxidase (Nox) activity. However,
macrophages exposed to Zn-depleted serum-free media mani-
fested36% increase in ROS, significantly higher (p < 0.01) than
activated infected macrophages (Figure 6A). These dataacrophages and from WT and Mt1/ Mt2/ mice and zoom in of labile Zn
WT, Mt1/Mt2/ macrophages. Data are mean ± SD, two independent ex-
ted macrophages compared to untreated control. Data are mean ± SEM, four
silenced macrophages. Percentage decrease in peak area is compared to
dependent experiments.
ation, n = 2.
tion and infection, n = 2.
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Figure 5. Early Regulation ofMtGenes and Role of Slc39a2 in MT-Zn
Sequestration
(A) qRT-PCR of Mt1, Mt2, Mt3, and Slc39a2; time points are min and hr after
infection. Data are mean ± SEM, n = 3 at 0–12 hr and n = 10 independent
experiments at 24 hr.
(B) qRT-PCR of Slc39a2, Mt1, and Mt2 in Slc39a2-silenced macrophages
normalized to scramble siRNA control, percentage decrease in expression
compared to respective scramble controls. Data are mean ± SEM, three in-
dependent experiments.
(C) Total metal analysis of Zn in lysates (left) and H. capsulatum (right) from
scramble siRNA and Slc39a2-silenced macrophages. Data are mean ± SD,
three independent experiments.
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facilitated increased oxidative burst, which was entirely revers-
ible upon addition of Zn.
The sources of cellular ROS include mitochondrial respiration
(Dro¨se and Brandt, 2012) and ROS produced by Nox (Minakami
and Sumimotoa, 2006). Nox contributes to phagosomal ROS
production that targets pathogens contained within these vacu-
oles. Activated macrophages from Ncf1/ mice failed to
generate an increased ROS response upon H. capsulatum chal-
lenge or Zn depletion (Figure 6B), indicating that reduction in
labile Zn specifically enhanced ROS generation via Nox. We
postulated that ROS production would be compromised in
Mt1/Mt2/ macrophages as a consequence of reduced Zn
sequestration. Although WT-activated infected macrophages
effectively induced an oxidative burst, this was dampened in
Mt1/Mt2/ macrophages (Figure 6E).
ROS was essential for H. capsulatum growth inhibition; mac-
rophages in which Nox was inhibited by apocynin and Ncf1/
macrophages had decreased ability to inhibit H. capsulatum
growth (Figure 6C). To discern whether the defensive action of
GM-CSF was a direct result of Zn limitation or enhanced ROS
caused by Zn deprivation, we subjected H. capsulatum to ROS
in vitro under Zn limitation. Though xanthine oxidase (XO) at a
higher concentration reduced growth in normal media, Zn limita-
tion greatly enhanced the inhibitory effect of ROS on
H. capsulatum growth, and this was reversible upon addition of
Zn (Figure 6D). To determine the mechanism by which Zn
sequestration facilitated increased Nox activity, we examined
the regulation of hydrogen voltage-gated proton channel
(Hvcn1). Macrophages enhanced Hvcn1 expression in response
to GM-CSF in a STAT3- and STAT5-dependent manner (Fig-
ure 6F; Figure S5A). Proton flux by HV1 accelerates ROS gener-
ation via Nox and Zn inhibits HV1 function (DeCoursey et al.,
2003). Addition of the protonophore, carbonyl cyanide m-chlor-
ophenyl hydrazone (CCCP) reversed the inhibitory effect of Zn on
ROS generation (Figure 6G). ROS production was attenuated in
Hvcn1-silenced and Hvcn1/ macrophages upon GM-CSF
activation and infection. Hvcn1/-activated macrophages
showed compromised ability to control H. capsulatum growth
compared to WT control (Figures 6G and 6H; Figures S5B and
S5C). These data signify the impact of Zn sequestration in
enhancing phagocyte defense via ROS production.
GM-CSF Drives Zn Binding to MT In Vivo
GM-CSF has a profound influence on the fate of infection in vivo
(Deepe et al., 1999). We hypothesized that GM-CSF signaling
was required for Zn sequestration in macrophages in vivo. In a
pulmonary model of H. capsulatum infection, F4/80+ CD11b+
GFP+ and F4/80+ CD11b+ GFP macrophages were sorted
from lung leukocytes of green fluorescent protein (GFP)
H. capsulatum-infected mice (Schematic, Figure 7A). F4/80+(D) SEC-ICP-MS chromatogram of scramble siRNA and Slc39a2-silenced
activated macrophages, y axis, offset Zn- signal. One of three independent
experiments is shown.
(E) Ratio of Zn to sulfur in the MT fraction collected from 19 to 21 min based on
the areas under the chromatogram corrected by differences in sensitivity
through calibration with S and Zn standards. Data are mean ± SD, three in-
dependent experiments. Related to Figure S4.
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MTs compared to F4/80+ CD11b+ GFP cells (Figure 7B; Figure
S6G). To evaluate the importance of GM-CSF in Zn binding to
MTs in vivo, we neutralized it and evaluated Zn profiles of macro-
phages 7 days after infection. There was a sharp reduction in Zn
bound toMTs in F4/80+CD11b+GFP+macrophages inGM-CSF-
neutralized mice, making it comparable to F4/80+ CD11b+ GFP
macrophages (Figure 7D). No alteration was seen in Rat
immunoglobulin G (IgG) controls (Figure 7C). We asked whether
GM-CSF neutralization enhanced fungal burden in macro-
phages. The percent and MFI of GFP+ cells in F4/80+ CD11b+
macrophages were higher in anti-GMCSF treated mice (Fig-
ure 7F). To further examine the importance of GM-CSF signaling
in Zn regulation, we adoptively transferredWTmacrophages into
Csf2ra/mice lacking the GM-CSF receptor, infected with GFP
H. capsulatum, andWT andCsf2ra/macrophageswere sorted
7 days after infection. Mt1, Mt2, and Slc39a2 expression was
enhanced in infectedWTmacrophages,whereasCsf2ra/mac-
rophages showed over 60%, 93%, and 97% decrease in Mt1,
Mt2, and Slc39a2 expression, respectively, compared to
infected WT macrophages (Figures 7G and 7H). Moreover, the
percent infectivity of F4/80+ CD11b+ GFP+ cells in Csf2ra/
mice was higher (16.7%) as compared to infected WT CD45.1
macrophages (1.26%). These data highlight the importance of
GM-CSF in regulating Zn during infection in vivo.GM-CSF Mediates Zn Sequestration in Macrophages
from Slc11a1+/+ Mice and from Humans
C57BL/6 mice used in this study lack a functional SLC11A1
protein (White et al., 2004). This prompted us to determine
whether Zn regulation was altered in the presence of this Fe
transporter. GM-CSF induced a similar Zn profile in macro-
phages from CBA/J mice that express functional SLC11A1 (Fig-
ures S6A–S6C). We askedwhether this phenomenon occurred in
human macrophages. Zn distribution was analyzed in GM-CSF
activated infected human macrophages compared with resting
control. There was a similarity between Zn profiles in human
and murine macrophages. Activation of human macrophages
with GM-CSF-elevated MT-Zn binding during infection (Fig-
ure 7E; Figure S6H). These data indicate that GM-CSF broadly
induces modulation of Zn in macrophages and that this is a
conserved mechanism between mice and humans. We also
determined whether GM-CSF promoted Zn sequestration
to a distinct clade of H. capsulatum, G186R. Activated
macrophages strongly induced Zn modulation via MTs and Zn
transporters upon infection with G186R H. capsulatum (Figures
S6D–S6F). Thus, Zn sequestration by GM-CSF arrests pathogen
survival by dually targeting fungal Zn acquisition and augmenting
oxidative damage to the fungus.DISCUSSION
This study revealed an underlying mechanism for the action of
GM-CSF in combating infection with an intracellular pathogen.
To date, the mechanism of GM-CSF function has not been fully
elucidated. We have demonstrated that GM-CSF signaling em-
powers macrophage defense by facilitating a dual outcome of
limitation of bioavailable Zn and simultaneous enhancement ofsuperoxide burst, which renders the pathogen susceptible to
the host.
During infection, GM-CSF reduced total Zn in yeasts but
enhanced Zn influx in macrophages. Although this finding
appears counterintuitive, GM-CSF induced an increase in the
Zn binding proteome, suggesting an enhancement of Zn-depen-
dent cellular functions such as transcription, enzyme function,
and metabolism (Beyersmann, 2002). To cope with pathogen in-
vasion, activated macrophages sequestered the exchangeable
Zn fraction away from intracellular fungus while concurrently
increasing ROS production.
We have reported that GM-CSF decreased total Zn in macro-
phages (Winters et al., 2010). The discrepancy between the cur-
rent and past study is a result of an improvement in the analytical
method, specifically in the blank correction of lysate analysis.We
went from a flow-injection analysis in a metal-containing system
to a continuous flow analysis in a metal-free system. The SEC-
ICP-MS chromatograms manifest the same results in both
studies with more total Zn in GM-CSF-activated and infected
peritoneal and bone-marrow macrophages than the resting
states by calculation of area under the curve. Also, total Zn in
H. capsulatum was consistent, because the metal-free system
was used in both studies. Thus, the observation that GM-CSF
activation induces a state of Zn sequestration and reduces total
Zn in H. capsulatum has been reproducibly demonstrated in this
study.
Confocal microscopy revealed that GM-CSF, but not TNF-
a-treated macrophages, route labile Zn into the Golgi, in associ-
ation with increased expression of Slc30a4 and Slc30a7
transporters that channel Zn into this organelle (Palmiter and
Huang, 2004). Zn deprivation in H. capsulatum was unique to
GM-CSF-activated macrophages, demonstrating the specificity
of this cytokine in Zn mobilization. The Golgi apparatus acts as a
site of labile Zn storage (McCormick et al., 2010) or a ‘‘Zn-stor-
age depot’’ in restricting Zn access to intracellular pathogens
while reserving it for phagocyte function. Fluorescent Zn probes
are an invaluable tool for imaging Zn, but their application is
affected by signal variation due to pH, ionic strength, and pro-
pensity to localize in acidic compartments (Tomat and Lippard,
2010). Although total cellular Zn is in micromolar range, the labile
Zn pool identified with Zinpyr-1 is in the picomolar range (Eide,
2006). Hence, the observed Zn signal might represent a fraction
of total Zn. Nevertheless, labile Zn is a crucial component of the
total Zn pool. Immune cells deliver Zn signals upon pathogen
contact and changes in labile Zn pool might reflect signal-trans-
ducing properties of this metal ion (Hirano et al., 2008).
Our observations withMt-silenced andMt1/Mt2/ macro-
phages reinforce the critical function of MTs in antimicrobial de-
fenses. In activated macrophages, MTs powered the loss of
pathogen-associated Zn. We demonstrate that MTs are essen-
tial mediators of GM-CSF function and their absence presents
a survival advantage to the pathogen. Of note, the WT control
used inMt1/Mt2/ studies (SvJ strain) depicted a Zn regula-
tory response similar to C57BL/6 macrophages. Thus, interfer-
ence with MT regulation impairs the antimicrobial effect induced
by GM-CSF.
We showed that both STAT5 and STAT3 orchestrate Zn mod-
ulation guided by GM-CSF. Disruption of STAT5 and STAT3
signaling abrogated MT-Zn sequestration. STAT5 and STAT3Immunity 39, 697–710, October 17, 2013 ª2013 Elsevier Inc. 705
Figure 6. Zn Sequestration Enhances ROS Production
(A) Percent change in ROS MFI in cells cultured in Zn replete, low Zn serum, low Zn serum+, 10 mM TPEN serum, 20 mM TPEN serum+, and 20 mM TPEN with
100 mMZnSO4 treated serum
+media. Serummedia that was included as serum-containingmedia has considerably higher Zn.Where serum+media was used, a
(legend continued on next page)
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GM-CSF Drives Zinc Sequestrationheterodimerize in the presence of granulocyte-CSF (Novak et al.,
1996); in this context, GM-CSF might also induce heterodimeri-
zation to regulate MT expression. We sought to explain Zn alter-
ation in infected macrophages by examining transporters. ZIP2
imports Zn into the cytosol from the extracellular milieu (Eide,
2006). Slc39a2 silencing reduced MT expression, but did not
affect the ability of MTs to sequester labile Zn. Upregulation of
Slc39a2 might indicate its involvement in cellular processes
that do not directly affect macrophage defense functions within
the analyzed 24 hr period of infection. It is also plausible that the
pathogen triggers Zn influx via ZIP2, an effect counteracted by
Zn sequestration in a GM-CSF primed macrophage.
Our findings reveal that Zn sequestration exerts a broader
impact on macrophage antifungal defense. Conflicting evidence
exists regarding the ability of Zn to trigger or dampen ROS pro-
duction (Bishop et al., 2007; DeCoursey et al., 2003). In activated
macrophages, a reduction in the labile Zn pool was clearly asso-
ciated with an increase in ROS that was dependent on Nox and
reversed by exposure to Zn. GM-CSF achieved this feat by a
2-fold regulatory mechanism: first, the cytokine upregulated
expression of Hvcn1 that elevates Nox activity; second, it
induced a Zn-limiting environment that promotes proton pump-
ing by HV1 and Nox function. Ncf1/- and Hvcn1/-activated
macrophages exhibited reduced growth-inhibitory effect on
H. capsulatum. Apocynin inhibits Nox but might also interfere
with NO production, and that might explain the increased
reversal of inhibition (Muijsers et al., 2000). Charge compensation
by K+ channels might account for the partial growth inhibitory
capacity seen in Hvcn1/-activated macrophages (Nauseef,
2007). An increased ROS triggers a variety of secondmessenger
signals, such as activation of STAT3 (Simon et al., 1998) and nu-
clear factor kappa B (Gloire et al., 2006) that possibly converge
into potent and sustained macrophage defense. From the path-
ogen perspective, Zn paucity might compromise microbial
protein functions such as superoxide dismutase activity that
mediates resistance to the host (Kehl-Fie et al., 2011). Metal
binding sites on proteins exhibit degeneracy (Heizmann and
Cox, 1998). Zn limitation to the pathogen can therefore poten-
tially enforce substitution of Zn-dependent metal-binding sites
on microbial proteins with more reactive metals, such as Cu
and Fe. Indeed, the ROS generated in vitro by XO exerted a pro-
found effect on H. capsulatum survival under Zn limitation.
Emphasizing the impact of Zn sequestration on ROS genera-
tion, we demonstrated that MTs are essential for an optimal
ROS response induced by GM-CSF. In the absence of MT1
and MT2, GM-CSF failed to effectively elevate ROS. Thesehigher concentration of TPEN was added (20 mM); last group is significantly diffe
sequestration. Abbreviations are as follows: Act, activated; Hc, H. capsulatum. T
(B) Percent change in ROS MFI in Ncf1/ activated macrophages, compared to
Ncf1/ macrophages.
(C) Percent inhibition of yeast growth in apocynin treated or Ncf1/ activated o
(D) CFU of H. capsulatum in normal or low Zn media with increasing concentrati
(E) Percent change in ROSMFI inWT andMt1/Mt2/macrophages compared
three independent experiments.
(F) Hvcn1 expression normalized to untreated macrophages, three independent
(G) Percent change in ROS MFI in WT-activated macrophages in response to
activated cells compared to WT, three independent experiments.
(H) Percent inhibition of H. capsulatum growth in infected and activated WT versu
data are mean ± SEM. Related to Figure S5.studies were performed at an early stage, because GM-CSF trig-
gers MTs immediately following infection. This observation is
surprising, because MTs bind metals but also scavenge ROS
(Maret, 2000). However, GM-CSF activated macrophages
remarkably elevated Zn sequestration by MTs. The oligomeric
shift in MTs might result from oxidation of Cys residues only dur-
ing later stages of infection.
We have reported that lack of GM-CSF leads to detrimental
fungal burden (Deepe et al., 1999). In this study, we found that
blockade of GM-CSF in vivo was sufficient to diminish Zn
sequestration and elevate macrophage fungal burden, signifying
that among several cytokines, GM-CSF uniquely modulates MT-
Zn homeostasis. This phenomenon might play a central role in
inhibition of fungal growth in vivo. These mechanisms are
conserved among different clades of H. capsulatum, among
strains of mice and humans.
In view of diversity in defensemechanisms against pathogens,
human macrophages employ a unique Zn-intoxication strategy
to limit growth of M. tuberculosis. Labile Zn deprivation by
GM-CSF reveals a mechanism by which the host might combat
intracellular pathogens. With these contrasting mechanisms of
Zn intoxication versus deprivation, it can be postulated that cyto-
kine-activated macrophages evolved to use specialized and
distinct defense arsenals against different pathogens. On the
other hand, microbes have evolved means to cope with nutrient
paucity. Salmonella typhimurium resists calprotectin-mediated
Zn deprivation by upregulating a high-affinity Zn transporter
(Liu et al., 2012). In contrast, H. capsulatum fails to cope with
Zn sequestration and enhanced free-radical challenge. Little is
known about Zn transporters in H. capsulatum, but one can
derive that although the organism strives to acquire Zn by
increasing import, the amount is insufficient to drive intracellular
growth. Of note, H. capsulatum does not have to confront an
elevated calprotectin in macrophages (Winters et al., 2010). On
the other hand, it has to compete for Zn acquisition with MTs,
which might be more potent than calprotectin in that each mole-
cule of the former scavenges seven ions with picomolar affinity
(Coyle et al., 2002), whereas the latter binds two Zn ions per
molecule with nanomolar affinity. (Kehl-Fie et al., 2011; Korndo¨r-
fer et al., 2007).
In summary, by using a combination of gene-expression anal-
ysis, microscopy, ICP-MS, and SEC coupled to ICP-MS and
proteomics, we have dissected a mechanism by which GM-
CSF-activated macrophages pose a dual defense system,
simultaneously challenging microbial tolerance to restricted Zn
availability coupled to increased oxidative damage. Lastly, werent (p < 0.01) from all groups. ROS histograms demonstrate the effect of Zn
wo to three independent experiments.
WT activated uninfected cells, three independent experiments, histogram from
ver WT macrophages, three independent experiments.
on of XO, with or without addition of ZnSO4, three independent experiments.
toWT uninfected cells. ROS histogram ofWT andMt1/Mt2/macrophages;
experiments.
infection, ZnSO4, and CCCP; two independent experiments; and Hvcn1
/
s Hvcn1/macrophages over WT control, three independent experiments; all
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Figure 7. GM-CSF Triggers Zn Binding to
MTs In Vivo and in Human Macrophages
(A) Schematic shows that mice were left untreated
or treated with rat IgG or anti-GM-CSF and in-
fected i.n. with 2 3 106 GFP+ yeasts (Hc). Lungs
were harvested 7 days after infection, and F4/80+
CD11b+GFP+ and F4/80+CD11b+GFP cells were
sorted.
(B–D) SEC-ICP-MS profiles of (B) F4/80+CD11b+
GFP+ and F4/80+ CD11b+GFP- cells isolated from
lungs, (C) Rat IgG treated, and (D) anti-GM-CSF
treated mice, two independent experiments.
(E) SEC-ICP-MS profiles of lysates from human
resting (h R) and GM-CSF activated (h Act) mac-
rophages; y axis, offset Zn signal; inset, zoom in of
15–25 min fraction, two independent experiments.
(F) Dot plot of lung leukocytes gated on F4/
80+CD11b+ macrophages; histogram of F4/80+
CD11b+GFP+ macrophages. Bar graphs are
quantification of percentage, absolute numbers,
and MFI of F4/80+CD11b+GFP+ macrophages in
rat IgG versus anti-GM-CSF treatedmice. Data are
mean ± SEM, n = 4.
(G) Schematic representing transfer of CD45.1
WT macrophages into CD45.2 Csf2ra/ mice
and infection and sorting of WT and Csf2ra/
macrophages from lungs for gene-expression
analysis.
(H) qRT-PCR ofMt1,Mt2, andSlc39a2 from sorted
CD45.1+ (WT) and CD45.1 (Csf2ra/) GFP and
GFP+ macrophages normalized to CD45.1+GFP
macrophages. Percentage values represent
the decrement in gene expression in Csf2ra/
CD45.1 GFP+ macrophages compared to WT
CD45.1+ GFP+ macrophages. Data are mean ±
SEM, data are from one experiment. Related to
Figure S6.
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strategy that can be extended to growth restriction of other intra-
cellular fungi. Whether macrophages preferentially employ labile
Zn deprivation over Zn intoxication for defense against distinct
microbial classes remains to be determined.708 Immunity 39, 697–710, October 17, 2013 ª2013 Elsevier Inc.EXPERIMENTAL PROCEDURES
See also Supplemental Experimental Procedures.
Mice
C57BL/6, CBA/J, Mt1tm1BriMt2tm1Bri (Mt1/
Mt2/), 129S1/SvImJ WT (control for
Mt1/Mt2/), and B6.SJL-Ptprca Pepcb/BoyJ
(CD45.1) mice were obtained from Jackson Labo-
ratory. We thank Dr. Bruce Trapnell, Cincinnati
Children’s Hospital Medical Center for the
Csf2ra/ mice; Dr. John Engelhardt, Dr. Yulong
Zhang (University of Iowa), Dr. Brahm Segal,
Dr. Nazmul Khan (Roswell Park Cancer Institute),
and Dr. Long-Jun Wu and Dr. Jiyun Peng (Rutgers
University) for providing bone marrow from
Ncf1/ and Hvcn1/ mice. Animals were main-
tained by the Department of Laboratory Animal
Medicine, University of Cincinnati, accredited by
the American Association for Accreditation of
Laboratory Animal Care (Frederick, MD), and ani-mal experiments were in accordance with Animal Welfare Act guidelines of
National Institutes of Health.
Activation, STAT Inhibition, and Infection
Bone-marrow macrophages were activated with cytokines for 24 hr before
infection. Peritoneal macrophageswere rested for 24 hr, followed by activation
Immunity
GM-CSF Drives Zinc Sequestrationfor 24 hr before infection, and were activated again during infection. Where
indicated, macrophages were cultured throughout with 100 mM STAT3 or
STAT5 inhibitors, S3I-201, and N0-((4-Oxo-4H-chromen-3-yl)methylene) nico-
tinohydrazide (Calbiochem), respectively. For infection, G217B or G186R
H. capsulatum were cultured in Ham’s F12 (Zn concentration, 250 ±
18 ng/ml or 4 mM) and washed before use.
Microscopy
Macrophages were infected with PKH-26 stained H. capsulatum for 24 hr fol-
lowed by staining with nuclear, Golgi, and Zn dyes where indicated for 30 min.
Images were acquired on a Zeiss LSM710 confocal and analyzed with ZEN
2011 software.
Silencing
Genes were silenced with TransIT-TKO transfection reagent (Mirus Bio LLC)
and 100 nM Mt (Santa Cruz), Slc39a2, Slc39a14, Stat3, or Stat5 (50 nM
each of Stat5a and Stat5b), Hvcn1, or scrambled siRNA (Dharmacon) as per
manufacturer’s instructions.
ROS
Macrophages were activated for 24 hr and then incubated with 5 mM Dihy-
droethidium (DHE) (Invitrogen) in fresh media for 15 min in dark, followed by
GM-CSF and infected for 2 hr. Where indicated, 100 mM ZnSO4 and TPEN
or Zn-depleted media was added 20 min prior to DHE. CCCP was added
30 min before analysis by flow cytometry (Accuri C6). Data were analyzed
with FCS Express 3 De Novo Software (CA) or FlowJo.
In Vivo
Eight-week-old C57BL/6 mice were infected with 23 106 GFP+H. capsulatum
yeasts intranasally (i.n.). Mice were injected intraperitoneally (i.p.) with 0.5 mg
control mAb Rat IgG2a (BioXcell) or MP1–22E9mAbRat IgG2a anti-GM-CSF a
day before and on the day of infection. After 7 days, lungs were homogenized
with gentleMACS Dissociator (Miltenyi Biotec, CA), collagenase treated,
filtered through 60 mM nylon mesh, and washed. Leukocytes were isolated
with Lympholyte M (Cedarlane Laboratories) and stained with APC F4/80
(AbD Serotec) and PerCP CD11b mAbs (BD Biosciences) and CD16/CD32
blocking mAbs for 30 min at 4C and washed; gated on F4/80+CD11b+ and
sorted into GFP+ (containing phagocytosed H. capsulatum) and GFP (not
containingH. capsulatum) with 5-laser FACS Aria II (BD Biosciences) in a BSLII
facility at Cincinnati Children’s Hospital; and collected at 4C in culture media
and washed prior to lysis. For adoptive transfer, 23 106 bone-marrow macro-
phages from WT (CD45.1) were transferred intratracheally into 8-week-old
Csfr2a/ (CD45.2) mice 1 day prior to H. capsulatum infection. On day 7 after
infection, lung leukocytes were sorted into four populations: F4/80+CD11b+
CD45.1+GFP or GFP+ and F4/80+CD11b+CD45.1GFP or GFP+ macro-
phages for analysis of gene expression.
Human Macrophages
PBMCs were isolated from human blood (Hoxworth Blood Center, University
of Cincinnati) with Ficoll-Paque.Monocytes were purifiedwithMonocyte Isola-
tion Kit II on a VarioMACS separator (Miltenyi Biotec) and cultured in RPMI with
12.5% human male AB serum (Sigma-Aldrich) for 7 days, and macrophages
were exposed to 10 ng/ml GM-CSF (Peprotech) or vehicle for 24 hr before
infection, re-exposed toGM-CSF at the time of infection, and lysateswere pre-
pared 24 hr later. Human experiments were approved by the Institutional Re-
view Board of the University of Cincinnati.
Cell Lysates for ICP-MS
Macrophages were washed and lysed with 0.1% sodium dodecyl sulfate
(SDS) in HPLC water for 20 min on ice. Lysates were passed through a
0.22 mmfilter or centrifuged at 13,000 rpm for 5min for analysis. For total metal
analysis of H. capsulatum, lysates were centrifuged at 13,000 rpm for 5 min to
pellet the yeasts and the pellet was washed twice with HBSS.
Total Elemental Analysis and SEC-ICP-MS Screening
ICP-MS analysis was performed on Agilent 77003 ICP-MS instrument (Agilent
Technologies). A conventionalMeinhard nebulizer, Peltier-cooled spray cham-
ber, and shield torch constituted the sample introduction system under stan-dard conditions. Sc was used as internal standard and SRM (DORM-3 or
NIST1745) were analyzed for every digestion.
For SEC-ICP-MS, Agilent 1100 series HPLC system equipped with a binary
pump, vacuum membrane degasser, thermostated auto sampler, column
oven, and diode array detector (DAD), with a semimicro flow UV-Vis cell was
coupled to the ICP-MS through a 0.17 mm internal diameter short PEEK
tube. The system was controlled with Chemstation software. A TSK Gel
3000SW 7.5 3 300 mm column was used. For proteomics, samples were
concentrated before injection with MWCO filter 3 kDa (Millipore). For analysis
of MT saturation, the MTs-SEC signal (20 min) was collected and analyzed for
S and Zn to determine the MT:Zn ratio in a Superdex peptide SEC-ICP-MS
with O2 reaction mode.
Proteomics
The SEC-ICP-MS fractions were analyzed with an Agilent 1200 nanoHPLC,
nanoChip ESI, and 6300 series MSD Ion Trap XCT Ultra system. Peptide
and corresponding protein identification were conductedwithMASCOT server
(Matrix Science).
Statistics
p values were calculated with one-way ANOVA for multiple comparisons and
adjusted with Bonferroni’s or Holm Sidak correction and nonpaired Student’s
t test where two groups were compared; *p < 0.05; **p < 0.01; ##p < 0.001; NS,
not significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.immuni.2013.09.006.
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